About Mariana Oncology
Mariana Oncology is a company based in Watertown (United States) founded in 2020 by Simon Read was acquired by Novartis in May 2024.. Mariana Oncology has raised $250 million across 2 funding rounds from investors including Lilly, Novartis and Citadel. The company has 41 employees as of December 31, 2022. Mariana Oncology offers products and services including Radioligand Therapies and Pipeline Programs. Mariana Oncology operates in a competitive market with competitors including Advanced Accelerator Applications, SOFIE, AdvanCell, Ariceum Therapeutics and Lantheus, among others.
- Headquarter Watertown, United States
- Employees 41 as on 31 Dec, 2022
- Founders Simon Read
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mariana Oncology, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mariana Oncology
Mariana Oncology offers a comprehensive portfolio of products and services, including Radioligand Therapies and Pipeline Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Precision therapies that deliver radioisotopes to target cancer cells selectively
Advancement of therapies for challenging cancers through innovative pipelines
Unlock access to complete
Unlock access to complete
Funding Insights of Mariana Oncology
Mariana Oncology has successfully raised a total of $250M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $175 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $175.0M
-
First Round
First Round
(01 Dec 2021)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series B - Mariana Oncology | Valuation | Forbion , Deep Track Capital | |
| Dec, 2021 | Amount | Series A - Mariana Oncology | Valuation | Atlas Venture , RA Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mariana Oncology
Mariana Oncology has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Novartis and Citadel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Founded Year | Domain | Location | |
|
Deep Track Capital is engaged in biotechnology investment activities.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mariana Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mariana Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mariana Oncology Comparisons
Competitors of Mariana Oncology
Mariana Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Accelerator Applications, SOFIE, AdvanCell, Ariceum Therapeutics and Lantheus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of molecular imaging systems and radio-pharmaceuticals
|
|
| domain | founded_year | HQ Location |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| domain | founded_year | HQ Location |
Developer of drugs for systemic targeted radiation therapy to treat cancer
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging agents and targeted therapeutics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mariana Oncology
Frequently Asked Questions about Mariana Oncology
When was Mariana Oncology founded?
Mariana Oncology was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Mariana Oncology located?
Mariana Oncology is headquartered in Watertown, United States.
Who is the current CEO of Mariana Oncology?
Simon Read is the current CEO of Mariana Oncology. They have also founded this company.
Is Mariana Oncology a funded company?
Mariana Oncology is a funded company, having raised a total of $250M across 2 funding rounds to date. The company's 1st funding round was a Series A of $75M, raised on Dec 01, 2021.
How many employees does Mariana Oncology have?
As of Dec 31, 2022, the latest employee count at Mariana Oncology is 41.
What does Mariana Oncology do?
Mariana Oncology was founded in 2020 and is headquartered in Watertown, United States. Operations center on the development of targeted radiopharmaceuticals for oncological applications, particularly solid tumors. Conjugates are rationally designed against biological targets to deliver alpha- and beta-emitting radionuclide payloads. Leadership is provided by Founder and CEO Simon Read, with activities focused in the biotechnology sector for cancer treatments.
Who are the top competitors of Mariana Oncology?
Mariana Oncology's top competitors include Advanced Accelerator Applications, SOFIE and AdvanCell.
What products or services does Mariana Oncology offer?
Mariana Oncology offers Radioligand Therapies and Pipeline Programs.
Who are Mariana Oncology's investors?
Mariana Oncology has 9 investors. Key investors include Lilly, Novartis, Citadel, RA Capital, and Atlas Venture.